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SUMMARY The term “tinea incognita” refers to diverse clinical presenta-
tion of mycotic infections modified by inappropriate use of topical or sys-
temic corticosteroids. A 67-year-old male patient with a five-year history 
of generalized erythematous plaques on the trunk and extremities, previ-
ously treated with topical corticosteroids, is described. The lesions main-
ly showed a psoriasiform, some eczematous appearance, few of them 
showing a clinical picture of folliculitis. The native mycologic specimen 
was negative. The diagnosis was made on the basis of mycologic culture 
finding of Trichophyton interdigitale growth. Systemic and topical antimy-
cotic therapy administered for two months resulted in complete regression 
of skin lesions.
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 INTRODUCTION
 The term “tinea incognita” refers to dermato-
phytic skin infections with a relatively characteris-
tic clinical picture of annular or oval erythematous 
lesions sometimes large in diameter, with marked 
scaly margins, modified by use of topical or sys-
temic corticosteroids (1). Tinea incognita may 
mimic the clinical picture of various dermatoses, 
thus posing an additional differential diagnostic 
problem. The diagnosis is based both on history 
and clinical picture, and generally confirmed by 
laboratory mycologic testing including native mi-
croscopy and culture. Pathohistologic examina-
tion is not routinely performed because the afore-
mentioned procedures usually prove adequate for 
diagnosis verification (2). However, pathohistol-
ogy is very useful in less clear cases. Mycelium 
elements may be visualized by various staining 
techniques such as periodic-acid-Schiff (PAS) or 
silver impregnation according to Grocott (2). The 
management of tinea incognita generally includes 
systemic antimycotic treatment (3). The course of 
the disease may be chronic due to modification 
of the typical clinical picture of dermatophytosis 
by topical corticosteroid therapy. The prognosis of 
the disease generally is highly favorable, as anti-
mycotic therapy nearly always results in complete 
recovery (4). 
 CASE REPORT
 Some 20 years before, a male patient now 
aged 67 observed desquamation and erythema 
involving the interdigital spaces of his feet. Five 
years before presentation, dissemination of the 
lesions in part showing eczematous and psoria-
siform appearance, some showing a clinical pic-
ture of folliculitis, occurred. The lesions involved 
almost the entire surface of the abdomen (Fig. 1) 
and lower extremities (Fig. 2). At the very onset 
of skin lesions, the patient applied topical cortico-
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steroids (betamethasone + salicylic acid cream), 
which resulted in partial regression of the lesions, 
i.e. reduction of inflammatory erythema and scal-
ing. Exacerbations of the disease occurred over 
the five consecutive years, the clinical picture be-
ing most pronounced in summer. Otherwise, the 
skin surface was free from any major alterations 
except for generalized toe nail discoloration and 
dystrophy, red and macerated, eroded and in-
flamed interdigital spaces, and minor dandruff on 
the scalp. Mycologic finding was negative on three 
occasions, whereas culture showed the presence 
of Trichophyton interdigitale. Skin biopsy revealed 
nonspecific inflammatory changes, folliculitis  and 
perifolliculitis (Figs. 3, 4 and 5). 
Figure 1. Clinical picture: eczematous, psoriasi-
form and folliculitis-like skin lesions in the abdomi-
nal region.
Figure 2. Clinical picture: the same picture is seen 
in lower extremities.
 Blood and urine biochemistry test results were 
normal; blood glucose 5.3 mmol/l; peripheral 
blood immunophenotyping yielded normal find-
ing: CD3+ (T) 77%; CD3+CD4+ 47%; CD3+CD8+ 
31%; CD4/CD8 1.52%; CD3-CD 16+56 (NK) 14%; 
CD3-CD19+ (B) 11%; functional lymphocyte tests 
Figure 3. Perifolliculitis – a mixed perifollicular in-
filtrate of mononuclear cells and neutrophils (he-
matoxylin-eosin stain; original magnification x25).
Figure 4. Perifolliculitis – detail (hematoxylin-eo-
sin stain; original magnification x50).
Figure 5. Scanty subepidermal perivascular in-
filtrate of mononuclear cells (hematoxylin-eosin 
stain; original magnification x25).
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(mitogenic) were normal: PHA 18.1, Con A 15.1, 
PWM 12.6, PPd 193; analysis of respiratory burst 
in granulocytes by flow cytometry also produced 
normal finding. IgG anti-HIV1 and IgG anti-HIV2 
findings were negative. A systemic antimycotic 
treatment with terbinafine, 250 mg daily, and mi-
conazole cream  topically was initiated. Two-month 
therapy resulted in complete regression of the skin 
lesions (Figs. 6 and 7). Hepatogram and the levels 
of cholesterol and triglycerides were normal both 
before and after terbinafine therapy. 
 DISCUSSION
 The presented case is an example of an im-
munocompetent individual in whom a generalized, 
unrecognized dermatomycosis was for five years 
treated as psoriasis with topical corticosteroids. 
Corticosteroids are potent agents, and their ef-
fects in the management of skin diseases include 
decreased epidermal mitotic activity, epidermal 
thinning, decrease in epidermal cell size, de-
creased overall intraepidermal metabolic activity, 
dermal thinning and decreased collagen synthesis 
(4), and reduction of inflammation (4,5). As they 
reduce inflammatory reaction, corticosteroids are 
widely used for radical treatment of many inflam-
matory dermatoses (4). Changes in the clinical 
picture are especially pronounced in case of inap-
propriate use of corticosteroids in the management 
of unrecognized dermatophytoses (4). Proper un-
derstanding of dermatophytic infections requires, 
among others, thorough knowledge of their ecol-
ogy (6). Some etiologic species predominantly re-
side in the soil (geophilic), on animals (zoophilic), 
or on humans (anthropophilic) (6,7). The geophilic 
and zoophilic species may sporadically infect hu-
Figure 7. The lesions on lower extremities also 
showed complete regression, with residual scar 
after skin biopsy.
Figure 6.  Two-month therapy resulted in com-
plete regression of abdominal skin lesions.
mans. The zoophilic species cause a more inflam-
matory response, sometimes with a suppurative 
clinical picture, primarily on the protected and un-
protected skin areas having been in direct contact 
with the soil and animal, respectively (3,6). The 
anthropophilic species cause inflammatory re-
action of lower severity, mostly localized on the 
protected skin areas (groins, knee, foot), and are 
usually transmitted by direct contact between the 
infected and healthy persons or indirectly through 
fomites (6). The severity of the clinical picture 
greatly depends on the host’s health status, pri-
marily on concomitant diseases such as diabetes 
mellitus, malignant diseases of the lymphatic sys-
tem, immunodeficiency, HIV/AIDS, Cushing’s syn-
drome, etc. (6). The host’s age, sex, race, lifestyle, 
occupation and geographical location also play an 
important role (6). Additional factors that stimulate 
the development of dermatophytosis include me-
chanical trauma compromising the protective role 
of the skin, hyperhidrosis, occlusive effect of the 
clothes, etc. (6). During the period of incubation, 
dermatophytes grow in the horny layer metaboliz-
ing keratin they feed on (6). Their presence in the 
horny layer evokes eczematous response in the 
underlying epidermis (5). Eczematous skin is a 
poor keratin producer, thus leaving the fungi with-
out food supply and resulting in spontaneous dis-
appearance of the infection (5). At the same time, 
the use of topical corticosteroids stimulates fungal 
growth by suppressing the local immune response, 
thus allowing for the occurrence of more virulent 
strains (5). Accordingly, corticosteroids reduce re-
sistance to infection, in this case mediated by cel-
lular immunity. This in turn increases the likelihood 
for the infection to proceed undiagnosed, addition-
ally increasing the patient’s susceptibility to infec-
tion. The period of incubation is usually free from 
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any clinical signs of infection, and dermatophytes 
can only be demonstrated in a native specimen 
(6). A typical clinical picture with annular erythem-
atous foci, scaling and pustules on the periphery, 
and intensive pruritus develops between day 10 
and 35 in persons with dermatophyte infection for 
the first time, whereas reinfection in the same per-
son produces a very early inflammatory response 
(6). Clinically, tinea incognita may mimic various 
dermatoses such as erythema chronicum migrans 
(8), contact dermatitis (3), psoriasis (3), lupus 
erythematosus (3,9), polymorphous light eruption 
(10), which thus frequently remain unrecognized 
and mistreated. Dermatophytosis on the face may 
also frequently be misdiagnosed, mimicking the 
clinical picture of seborrheic dermatitis (11,12), 
contact dermatitis (11,12), lupus erythematosus 
(11,12), photosensitive dermatitis (11,12) and 
rosacea (12), especially in adults, with papules, 
pustules and patches of erythema, with or without 
scaling, and with absence of typical annular le-
sions (12). Patients with this problem consistently 
report on previous treatment of the disease with 
topical or systemic corticosteroids (4), prescribed 
by the physician or, by no means infrequently, as 
self-treatment, as some corticosteroids are also 
available as over-the-counter (OTC) agents (11). 
It should be borne in mind that a dermatophytic 
infection may be overlooked in psoriatics using 
topical corticosteroids (4), which especially ap-
plies to patients with inverse psoriasis in whom 
newly developed erythema and scaling lesions 
may be considered and treated as psoriasis with 
topical corticosteroids, while being actually under-
lain by ringworm infection rather than psoriasis. 
Therefore, making the diagnosis exclusively on 
the basis of clinical picture may result in inappro-
priate topical corticosteroid therapy, which visibly 
reduces infiltration and scaling in dermatophyto-
ses but the symptoms will recur soon after therapy 
discontinuation. In chronic dermatophytosis, the 
reservoir of infection are dermatophytes found in 
hair follicles (9), reaching them during the process 
of hair keratin fermentation. In our patient, the 
histologic picture was predominated by folliculitis, 
whereas specific staining failed to demonstrate 
fungal elements either in the follicles or in the 
horny layer. We are inclined to believe that follicles 
served as a reservoir of infection, disseminating 
to the groin and abdominal region by autoinocu-
lation from interdigital spaces of the feet. That is 
why some authors suggest that stockings be put 
on first, before all other clothes (7). In our patient, 
the chronic course of the disease was, among oth-
ers, induced by the lesions having been caused by 
an anthropophilic species (T. interdigitale), which 
induces weak inflammatory response that was ad-
ditionally suppressed by longterm corticosteroid 
therapy. The exact mechanisms by which some 
immunocompetent persons like our patient de-
velop persistent and recurrent dermatophytic skin 
infection have not yet been fully clarified. Some 
experimental studies have shown that persistent 
infection occurs due to the secondary local inhibi-
tory effect of dermatophytic antigens in vivo or to 
selective anergy to dermatophyte antigens (13). 
The role of specific mechanisms of defense is not 
clear, however, cellular immunity is known to play 
a more important role than humoral immunity (2), 
the latter still awaiting full elucidation. Patients with 
extensively disseminated dermatophytosis have 
high titers of IgG, IgM and IgA antibodies, which 
are not dermatophyte specific (6). A high IgE ti-
ter indicates a chronic course of the disease and 
is frequently detected in associated atopy (14). It 
has been speculated that the occurrence of infec-
tion could be explained by local or systemic modu-
lation of T lymphocyte activity as well as by acti-
vation of helper lymphocytes (14). In our patient, 
both basic and specific diagnostic tests failed to 
confirm the disease, i.e. immunosuppression sup-
porting dermatophytic infection. Positive culture is 
the gold standard for accurate diagnosis, however, 
the diagnosis is verified by the finding of hyphae or 
spores in native specimen, or mycelial elements in 
pathohistologic specimen (2). The treatment with 
systemic antimycotics has to be initiated when the 
mycotic infection is proved (5). 
 CONCLUSION
 Mycotic infection should always be considered 
in case of persistent and recurrent skin lesions 
resembling other dermatoses. Thorough history, 
careful laboratory testing with particular reference 
to mycologic culture findings, and skin biopsy in 
vague cases are necessary procedures to reach 
an accurate diagnosis of dermatophytic skin infec-
tion. Some experienced dermatologists suggest 
that mycologic examination should only be done 
in two instances, i.e. when the clinical picture is 
typical for fungal skin infection, and when it bears 
no such resemblance at all.
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